Details for Patent: 10,143,693
✉ Email this page to a colleague
Which drugs does patent 10,143,693 protect, and when does it expire?
Patent 10,143,693 protects INVEGA TRINZA and is included in one NDA.
This patent has forty patent family members in twenty-five countries.
Summary for Patent: 10,143,693
| Title: | Dosing regimen for missed doses for long-acting injectable paliperidone esters |
| Abstract: | The present application provides a method for treating patients in need of psychiatric treatment, wherein said patient is being treated with the 3-month formulation of paliperidone palmitate and fails to take the next scheduled dose of the 3-month formulation of paliperidone palmitate. |
| Inventor(s): | Gopal; Srihari (Belle Mead, NJ), Ravenstijn; Paulien Gerarda Maria (Waalre, NL), Russu; Alberto (Lange Nieuwstraat, BE), Samtani; Mahesh Narain (Flemington, NJ) |
| Assignee: | Janssen Pharmaceuticals, Inc. (Beerse, BE) |
| Application Number: | 15/090,889 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 10,143,693 |
|
Patent Claim Types: see list of patent claims | Use; |
Drugs Protected by US Patent 10,143,693
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Janssen Pharms | INVEGA TRINZA | paliperidone palmitate | SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 207946-001 | May 18, 2015 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | REINITIATION OF SCHIZOPHRENIA TREATMENT FOLLOWING A MISSED DOSE 4-9 MONTHS AGO | ⤷ Try a Trial | ||||
| Janssen Pharms | INVEGA TRINZA | paliperidone palmitate | SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 207946-001 | May 18, 2015 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | REINITIATION OF SCHIZOPHRENIA TREATMENT FOLLOWING A MISSED DOSE MORE THAN 9 MONTHS AGO | ⤷ Try a Trial | ||||
| Janssen Pharms | INVEGA TRINZA | paliperidone palmitate | SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 207946-002 | May 18, 2015 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | REINITIATION OF SCHIZOPHRENIA TREATMENT FOLLOWING A MISSED DOSE MORE THAN 9 MONTHS AGO | ⤷ Try a Trial | ||||
| Janssen Pharms | INVEGA TRINZA | paliperidone palmitate | SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 207946-002 | May 18, 2015 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | REINITIATION OF SCHIZOPHRENIA TREATMENT FOLLOWING A MISSED DOSE 4-9 MONTHS AGO | ⤷ Try a Trial | ||||
| Janssen Pharms | INVEGA TRINZA | paliperidone palmitate | SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 207946-003 | May 18, 2015 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | REINITIATION OF SCHIZOPHRENIA TREATMENT FOLLOWING A MISSED DOSE 4-9 MONTHS AGO | ⤷ Try a Trial | ||||
| Janssen Pharms | INVEGA TRINZA | paliperidone palmitate | SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 207946-003 | May 18, 2015 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | REINITIATION OF SCHIZOPHRENIA TREATMENT FOLLOWING A MISSED DOSE MORE THAN 9 MONTHS AGO | ⤷ Try a Trial | ||||
| Janssen Pharms | INVEGA TRINZA | paliperidone palmitate | SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 207946-004 | May 18, 2015 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | REINITIATION OF SCHIZOPHRENIA TREATMENT FOLLOWING A MISSED DOSE 4-9 MONTHS AGO | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 10,143,693
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2016244801 | ⤷ Try a Trial | |||
| Australia | 2020239611 | ⤷ Try a Trial | |||
| Australia | 2022221405 | ⤷ Try a Trial | |||
| Brazil | 112017021383 | ⤷ Try a Trial | |||
| Canada | 2925908 | ⤷ Try a Trial | |||
| Canada | 3088401 | ⤷ Try a Trial | |||
| Cyprus | 1123203 | ⤷ Try a Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
